veeva analyst & investor day...started 2010 with vault separated company and product processes...
TRANSCRIPT
![Page 1: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/1.jpg)
![Page 2: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/2.jpg)
Veeva Analyst & Investor DayOctober 4, 2018
![Page 3: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/3.jpg)
3Copyright © Veeva Systems 2018
2018 Veeva Analyst & Investor Day
Veeva Vision Peter Gassner, Founder & CEO
Industry Perspectives Matt Wallach, Co-founder & President
Veeva Commercial Cloud Paul Shawah, SVP, Commercial Cloud
Veeva Development Cloud Henry Levy, GM, Vault CDMS
Customer Success Dan Utzinger, Intra-Cellular Therapies
Financial Update Tim Cabral, CFO
Q&A All
![Page 4: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/4.jpg)
4Copyright © Veeva Systems 2018
Safe HarborForward-looking Statements
This presentation contains forward-looking statements, including statements regarding Veeva's future financial outlook and financial performance, market growth, the release dates for and benefits from
the use of Veeva's solutions, our partnership plans, our strategies, and general business conditions. Any forward-looking statements contained in this presentation are based upon Veeva's historical
performance and its current plans, estimates and expectations and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent
Veeva's expectations as of the date of this presentation. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the
future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including (i) breaches in our security measures or
unauthorized access to our customers’ data; (ii) our expectation that the future growth rate of our revenues will decline; (iii) fluctuation of our results, which may make period-to-period comparisons less
meaningful; (iv) competitive factors, including but not limited to pricing pressures, consolidation among our competitors, entry of new competitors, the launch of new products and marketing initiatives
by our existing competitors, and difficulty securing rights to access, host or integrate with complementary third party products or data used by our customers; (v) the rate of adoption of our newer
solutions and the results of our efforts to sustain or expand the use and adoption of our more established applications, like Veeva CRM; (vi) loss of one or more customers, particularly any of our large
customers; (vii) system unavailability, system performance problems, or loss of data due to disruptions or other problems with our computing infrastructure; (viii) failure to sustain the level of profitability
we have achieved in the past as our costs increase; (ix) adverse changes in economic, regulatory, or market conditions, particularly in the life sciences industry, including as a result of customer mergers;
(x) our ability to attract and retain highly skilled employees and manage our growth effectively; (xi) a decline in new subscriptions that may not be immediately reflected in our operating results due to the
ratable recognition of our subscription revenue; and (xii) pending, threatened, or future legal proceedings and related expenses.
Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results
of Operations” in the company’s filing on Form 10-Q for the period ended July 31, 2018. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at
sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.
![Page 5: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/5.jpg)
Veeva VisionPeter Gassner, Founder & CEO
![Page 6: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/6.jpg)
6Copyright © Veeva Systems 2018
VisionBuilding the Industry Cloud for Life Sciences
ValuesDo the Right ThingCustomer SuccessEmployee SuccessSpeed
![Page 7: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/7.jpg)
7Copyright © Veeva Systems 2018
Key Highlights
• Continued Innovation and Significant Market Expansion
• Long-term Leadership in Strategic Markets
• Powerful and Unique Cloud Platform
• Business Model Advantage – The Veeva Way
![Page 8: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/8.jpg)
8Copyright © Veeva Systems 2018
The Veeva Way
Customer Success
Innovation & Product Excellence
Strong Growth & Profitability
Big Strategic Markets
Copyright © Veeva Systems 2018
![Page 9: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/9.jpg)
9Copyright © Veeva Systems 2018
Strong Growth and Profitability
Fiscal Year Ending January 31¹ A reconciliation of GAAP to non-GAAP measures is set forth in Appendix 1.² Restated for ASC 6063 Based on our latest guidance issued 8/23/2018
FY’12 FY’13 FY’14
Revenue Non-GAAP Operating Income1
$61M
$130M
$210M
$313M
$409M
$551M
$7M$30M
$47M
$86M$109M
$173M
FY’15 FY’16 FY’17²
$29M$5M
FY’11 FY’18²
$691M
$219M
FY’193
$840-843M
$281-284M
![Page 10: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/10.jpg)
10Copyright © Veeva Systems 2018
Commercial Cloud
Development Cloud
Outside Life Sciences
Major Areas of the Business
![Page 11: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/11.jpg)
11Copyright © Veeva Systems 2018
LIFE SCIENCES
Drug Development Systems
Commercial Systems
Strategic Technology Partner to Life Sciences
![Page 12: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/12.jpg)
12Copyright © Veeva Systems 2018
Commercial VaultCRM Suite
Commercial Offerings
![Page 13: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/13.jpg)
13Copyright © Veeva Systems 2018
Innovation in Commercial
2007 2009 2011 2013 2015 2017 2019
Today
OpenData
Align
Network
CRM Suite
Nitro AndiPharma CRM
Global CRM
Core CRM What’s Next
Events
![Page 14: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/14.jpg)
14Copyright © Veeva Systems 2018
Nitro
Engage
Approved Email
MedComms
PromoMats
CRM
INNOVATORS EARLY ADOPTERS EARLY MAJORITY MIDDLE MAJORITY LATER ADOPTERS
CLM
Building Product Leadership in Commercial
Align
OpenData
Events
Network
Market Share
![Page 15: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/15.jpg)
Looking Ahead
![Page 16: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/16.jpg)
16Copyright © Veeva Systems 2018
Intelligent Customer Engagement
EmailText
Commercial Data Warehouse
Customers
Field Reps
Suggestions
Feedback
Face-to-Face, Email, Remote
future
AI Engine
future
![Page 17: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/17.jpg)
17Copyright © Veeva Systems 2018
future
![Page 18: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/18.jpg)
18Copyright © Veeva Systems 2018
2011 2013 2015 2017 2019
Today
eTMF
QualityDocs
Submissions
Content ManagementApplications
EDC
CTMSRegistrations QMS
Data Applications
CDMS
Safety
Publishing
Training
What’s Next
Innovation in Development Cloud
![Page 19: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/19.jpg)
19Copyright © Veeva Systems 2018
INNOVATORS EARLY ADOPTERS EARLY MAJORITY MIDDLE MAJORITY LATER ADOPTERS
Training
CDMS
CTMS
Submissions
QualityDocs eTMF
QMSStudy Startup
Subs Archive
Publishing
Registrations
SiteDocs
Market Share
Building Product Leadership in Development Cloud
![Page 20: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/20.jpg)
Looking Ahead
![Page 21: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/21.jpg)
21Copyright © Veeva Systems 2018
Clinical Collaboration Today
CROs
Sponsors
Sites
![Page 22: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/22.jpg)
22Copyright © Veeva Systems 2018
CROs
Sponsors
Sites
![Page 23: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/23.jpg)
23Copyright © Veeva Systems 2018
CROs
Sponsors
Sites Clinical Data Exchange
Coming mid-2019
![Page 24: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/24.jpg)
24Copyright © Veeva Systems 2018
New for Clinical Research Sites
Available Now
Clinical Document Management for Sites
![Page 25: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/25.jpg)
Veeva Outside Life Sciences
![Page 26: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/26.jpg)
26Copyright © Veeva Systems 2018
Initial Target IndustriesConsumer Goods | Chemicals | Cosmetics | Industrial Products
![Page 27: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/27.jpg)
27Copyright © Veeva Systems 2018
Document Control Training NCR & Investigation CAPA
AuditsComplaints Change ControlSupplier Quality
Comprehensive Quality Solution
![Page 28: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/28.jpg)
28Copyright © Veeva Systems 2018
Progress Since Last Year
• Progressing well in the Veeva Way
• 31 customers
• First seven-figure customer
• $10M+ in total revenue expected this year
• Expansion to Europe
![Page 29: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/29.jpg)
29Copyright © Veeva Systems 2018
Learnings
• Veeva Way works well outside life sciences
• Expansion to Europe going well
• Interest beyond QualityOne− QualityOne is the lead
− Regulatory applications of interest to consumer goods, cosmetics, chemicals
− Clinical applications of interest to consumer goods and cosmetics
− Common platform is a benefit
![Page 30: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/30.jpg)
30Copyright © Veeva Systems 2018
Looking Ahead for QualityOne
• More Customers
• Refine Products
• Refine Processes
• Establish Long-term Leadership
• Execution Matters Most!
![Page 31: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/31.jpg)
31Copyright © Veeva Systems 2018
Expanding the Model Over Time
Started 2010 with Vault
Separated company and product processes
Five years to operational excellence
Veeva as a Multi-Product Company
Started 2016 with Vault outside life sciences
Separating company and industry processes
Five years to operational excellence
Veeva as a Multi-Industry Company
![Page 32: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/32.jpg)
Vault Platform
![Page 33: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/33.jpg)
33Copyright © Veeva Systems 2018
FOR VEEVA
Building Applications
Fast development
High quality
Efficient
FOR CUSTOMERSPOWERThe
of
CONTENT + DATA
Using Applications
Customize
Integrate
Extend
![Page 34: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/34.jpg)
34Copyright © Veeva Systems 2018
Vault Platform Progress
Supporting New Applications &
Industries
Features, Function, Scale
Migrated to AWS
Getting ready for the next leap
![Page 35: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/35.jpg)
35Copyright © Veeva Systems 2018
On a Path to Multi-Billion Dollar Cloud Leader
• Continued Innovation and Significant Market Expansion
• Long-term Leadership in Strategic Markets
• Powerful and Unique Cloud Platform
• Business Model Advantage – The Veeva Way
![Page 36: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/36.jpg)
Industry PerspectiveMatt Wallach, Co-founder & President
![Page 37: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/37.jpg)
37Copyright © Veeva Systems 2018
Significant Investment in R&DR&D as a percentage of sales
3.1%
3.7%
5.8%
6.7%
7.9%
13.4%
17.5%
19.9%
All Manufacturing
Transportation
Aerospace
Chemical
Medical Equipment
Computer & Electronic
Semiconductor
Life Sciences
Average R&D spend as percentage of Sales from 2000 – 2013Source: IP-Intensive Manufacturing Industries: Driving U.S. Economic Growth, ndp | analytics (September 2017)
![Page 38: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/38.jpg)
38Copyright © Veeva Systems 2018
Innovative Therapies in Development74% of medicines in the pipeline are “First in Class”
2011 2016First in Class Not First in Class
9,526
7,982
74%69%
1 2
Sources: 1 Innovation in the Biopharmaceutical Pipeline: A Multidimensional View (Analysis Group, January 2013).2 The Biopharmaceutical Pipeline: Innovative Therapies in Clinical Development (Analysis Group, July 2017).
26%
31%
![Page 39: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/39.jpg)
39Copyright © Veeva Systems 2018
Steady Stream of New Drug Approvals
27
4145
22
46
2013 2014 2015 2016 2017 2018
43 (YTD)
Source: FDA.gov as of Oct 3, 2018
![Page 40: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/40.jpg)
40Copyright © Veeva Systems 2018
Key Partner to the IndustryTop 10 life sciences software vendors by spend
Sources: IDC, Vendor Assessment, #HI240273, March 2013, IDC, Market Share, #US43964017, June 2018
Veeva
Medidata
Oracle
SAP
Dassault
SAS
Parexel
IQVIA
Thermo Fisher
Model N
Oracle
SAP
Medidata
SAS
Accelrys
Thermo Fisher
Cegedim
Parexel
Veeva
TIBCO
1
2
3
4
5
6
7
8
9
10
2012 2017
![Page 41: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/41.jpg)
41Copyright © Veeva Systems 2018
Veeva’s TAM is Now $9B+
$8B+Vault QualityOne
Commercial Cloud
$3B
Vault
$4B+
$1B+
Vault QualityOne
$9B+
Commercial Cloud
$3B
Vault
$4B
$1B+
$1B+ New Vault Products Data Workbench, Safety,
SiteDocs, Training
![Page 42: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/42.jpg)
42Copyright © Veeva Systems 2018
70 75
123136
109120
161
189
140
181
221
259
Regulatory Quality Clinical Commercial
Q2'17 Q2'18 Q2'19
31%
60%
39%
56%
Vault Customer Count Up Across All Areas
37%
51%
37%
28%
![Page 43: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/43.jpg)
43Copyright © Veeva Systems 2018
Vault Adoption AcceleratingAverage Vault products per Vault customer
FY14 FY15 FY16 2Q18FY17FY14 FY15 FY16 2Q19FY17 FY18
1.48 1.52 1.53
2.20
1.82
2.10
69CUSTOMERS
135 219 504CUSTOMERS CUSTOMERS CUSTOMERS
334CUSTOMERS
449CUSTOMERS
![Page 44: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/44.jpg)
44Copyright © Veeva Systems 2018
First year Q2'19
Annualized Vault subscriptionrevenue by annual cohort
2013 2014 2015 2016 2017 2018
3.8x
10.2x
31.1x
4.0x
1.6x
Vault Customers Expand Over Time
Average Vault products per
customer
2.8
3.0
3.4
2.6
2.42.2x1.6
![Page 45: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/45.jpg)
45Copyright © Veeva Systems 2018
FY14 FY15 FY16 2Q18FY17FY14 FY15 FY16 2Q19FY17 FY18
1.90
2.22
2.47
3.042.84 2.91
147CUSTOMERS
190 212 308CUSTOMERS CUSTOMERS CUSTOMERS
259CUSTOMERS
294CUSTOMERS
Customers Adopting More Commercial Cloud Average Commercial Cloud Products per Customer
![Page 46: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/46.jpg)
46Copyright © Veeva Systems 2018
Lots of White Space RemainingSubscription dollar penetration within
large enterprise customers with current products
~25% ~10%
Commercial Cloud Vault
![Page 47: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/47.jpg)
Veeva Commercial CloudPaul Shawah, SVP, Commercial Cloud
![Page 48: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/48.jpg)
48Copyright © Veeva Systems 2018
EFFICIENT AGILE EFFECTIVE
Shift to specialty
Pricing pressure
Pay for outcomes
Customer expectations
Industry Trends
![Page 49: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/49.jpg)
49Copyright © Veeva Systems 2018
Commercial Evolution
Present FuturePast
Face-to-Face
Intelligent Engagement
Digitally Enabled
![Page 50: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/50.jpg)
50Copyright © Veeva Systems 2018
Execution ContentIntelligenceCRM Suite Nitro & Andi Commercial Vault
Commercial Offerings
![Page 51: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/51.jpg)
51Copyright © Veeva Systems 2018
CRM
OpenData AlignEvents
Management Network
Approved Email EngageCore CRM & CLM
![Page 52: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/52.jpg)
52Copyright © Veeva Systems 2018
Vault PromoMats
Creative Collaboration
PreviewApproval
Multichannel Distribution
Digital Asset Management
Brand Portal
![Page 53: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/53.jpg)
53Copyright © Veeva Systems 2018Copyright © Veeva Systems 2018
Sunrise UI
![Page 54: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/54.jpg)
54Copyright © Veeva Systems 2018
Brand PortalThe Digital Store Front
![Page 55: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/55.jpg)
55Copyright © Veeva Systems 2018
AugmentedReality
![Page 56: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/56.jpg)
56Copyright © Veeva Systems 2018
Continuous Innovation
Veeva Innovation
120+MAJOR ENHANCEMENTS
Year-to-Date
IndustryBest Practices
Regulatory Requirements
![Page 57: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/57.jpg)
57Copyright © Veeva Systems 2018
Veeva Customer Trends
Move to digital
CRM expansions
SMBs go all-in
Growth of add-ons
![Page 58: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/58.jpg)
58Copyright © Veeva Systems 2018
CRM: Enterprise Expansions
Top 10 Pharma 1
Became a customer
2009
15+ countries
5,000+ users
Approved Email
40+ countries
20,000+ users
Global PromoMats
20142013 2018-19. . . . . .
Top 10 Pharma 2
Became a customer
110+ countries
25,000+ users
Global Approved Email & Events
Global PromoMats
10+ countries
15,000+ users
2014 2018-19. . . 2011 2015
Approved Email
. . .
![Page 59: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/59.jpg)
59Copyright © Veeva Systems 2018
Case Study: Biotech Goes All-In
4-week implementation
Ready for commercial launch
• Pre-commercial
• Oncology focus
• Novel therapies
• Approval expected Fall 2018
CRM ⚫ CLM ⚫ Network
OpenData ⚫ PromoMats
Align ⚫ MedComms ⚫ Nitro
Emerging Biotech Commercial Cloud
![Page 60: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/60.jpg)
60Copyright © Veeva Systems 2018
0.2
1
3
7.8
15
0
2
4
6
8
10
12
14
16
2014 2015 2016 2017 2018
Email Sends (millions)
14M
*Compares calendar year 2015 to projected calendar year 2018
64%CRM users with Approved Email
13xMore emails
sent*
5xMore emails
sent per user*
2018
Global Growth
![Page 61: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/61.jpg)
61Copyright © Veeva Systems 2018
Engage Meeting: Early Market Adoption
20+CUSTOMERS
40+COUNTRIES
4xCALL DURATION*
*Compared to reported industry average
![Page 62: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/62.jpg)
Intelligent Engagement
![Page 63: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/63.jpg)
63Copyright © Veeva Systems 2018
DATA
DELIVERY
ARTIFICIAL INTELLIGENCE
![Page 64: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/64.jpg)
64Copyright © Veeva Systems 2018
Delivery
TAKE ACTIONVIEW SUGGESTIONS
1 2
![Page 65: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/65.jpg)
65Copyright © Veeva Systems 2018
The Data Layer is Difficult
Extraction
, transfo
rmatio
n, lo
adin
g pro
cesses
Raw data
Transactional data staging Operational
store
Analytic data store
Field reporting data mart
BI/Reporting
Reference data staging
Master data storage
Field medical data mart
Sales data
Market data
Wholesaler data
Activity
Digital
Claims
HCP
Organization
Employee
Payer/plan
Patient
Expense AI
Co-Promote Partners
Other SystemsOther data martExtractio
n, tran
sform
ation
, load
ing p
rocesses
Data Sources
Data d
istribu
tion
![Page 66: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/66.jpg)
66Copyright © Veeva Systems 2018
Next-generation Data Warehouse
Sales data
Market data
Wholesaler data
Activity
Digital
Claims
HCP
Organization
Employee
Payer/plan
Patient
Expense
---Transactional---
---Master--
Data Sources
BI/Reporting
AI
Co-Promote Partners
Other Systems
![Page 67: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/67.jpg)
67Copyright © Veeva Systems 2018
Months…
✓ Analytics requirement
✓ Define data model
✓ Load data in staging layer
✓ Build operational data model
✓ Create mappings to operational store
✓ Transform to operational data model
✓ Transform to analytic data model
CRM Custom Data Warehouse CRM Nitro
Minutes
![Page 68: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/68.jpg)
68Copyright © Veeva Systems 2018
Nitro Early Adopters
Multiple data sets
No data warehouse
PRE-COMMERCIAL COMPANY
COMMERCIAL COMPANY
Replacing legacydata warehouse
Multiple data sets
![Page 69: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/69.jpg)
69Copyright © Veeva Systems 2018
Product Excellence Ecosystem Stays
CurrentBuilt for AI
![Page 70: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/70.jpg)
70Copyright © Veeva Systems 2018
Introducing
Available late 2019
![Page 71: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/71.jpg)
71Copyright © Veeva Systems 2018
Andi Driving Action
Call ActivityHistoric Model
Cycle PlanAdherence Model
AvailabilityHistoric Model
Suggest TargetYes/No
Call RatingDerived Model
Target RatingDerived Model
TRx/NRxSegment Model
TargetYes/No
Suggestion
Field Reps
1. Generate Suggestions 2. View Suggestions 3. Take Action
Feedback
![Page 72: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/72.jpg)
72Copyright © Veeva Systems 2018
Summary
Move to digital
Expand CRM leadership
SMBs go all-in
Growth of add-ons
Ready for AI
![Page 73: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/73.jpg)
Veeva Development CloudHenry Levy, GM, Vault CDMS
![Page 74: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/74.jpg)
74Copyright © Veeva Systems 2018
future
![Page 75: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/75.jpg)
75Copyright © Veeva Systems 2018
“Next year, I want to present how to implement
10 vaults in 18 months.”
- CIO, Midsize Biotech
2018 R&D Summit
1,400+attendees
250+customer
companies
![Page 76: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/76.jpg)
76Copyright © Veeva Systems 2018
• eTMF adoption expanding across sponsors and CROs
• First top 10 Study Startup customer live
• Rapid CTMS adoption. Initiating enterprise engagement
Clinical Operations Update
eTMF | Study Startup | CTMS
![Page 77: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/77.jpg)
77Copyright © Veeva Systems 2018
• 140 regulatory customers
• Publishing ready for early adopters
• Completing the suite – innovation and integration
Regulatory Update
Submissions | Submissions Archive | Registrations | Publishing
![Page 78: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/78.jpg)
78Copyright © Veeva Systems 2018
• 180 quality customers
• Transforming quality across documents and data
• Training ready for early adopters
• Completing the suite
Quality Update
QualityDocs | QMS | Training
![Page 79: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/79.jpg)
79Copyright © Veeva Systems 2018
• Deep area – no innovation in a decade
• On track for delivery in early 2019
• Significant customer interest
• Early focus on SMB
Vault Safety
Coming Soon
![Page 80: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/80.jpg)
Reinventing Clinical Data Management
![Page 81: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/81.jpg)
81Copyright © Veeva Systems 2018
Veeva Vault EDC Progress
* Industry average 10 weeks (Tufts Center for the Study of Drug Development)
Customers Top 20 customer
Therapeutic areas
Trials locking in October
Average weeks to DB build*
16 1
9 3 7
![Page 82: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/82.jpg)
82Copyright © Veeva Systems 2018
Evolution of Clinical Data Management
1980s
• All paper
• Simple central repository for cleaning and reporting
1990s
• First EDC solutions
• Optimism and experimentation
2000s
• EDC takes off, but unable to handle all types of data
• Tactical solutions for cleaning and reporting
2010s
• Proliferation of data (e.g. mHealth)
• No modern, holistic clinical data management solutions
• Inefficient and expensive
![Page 83: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/83.jpg)
83Copyright © Veeva Systems 2018
Example of Data Flow – Blood Pressure
1. Physician takes patient blood pressure (BP)
2. Physician enters BP into EHR
3. Assistant creates paper record for research entry
4. Assistant enters BP into EDC
Research Site Sponsor
5. Sponsor reviews individual BP in EDC
6. Sponsor reviews all patient BP in separate cleaning database
7. Sponsor reports data from a separate clinical data warehouse
• Burden on the sites
• Data replicated at least three times at sponsor
• Massive costs for data transfer and integration
• Complexity explodes with outsourcing and co-development
![Page 84: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/84.jpg)
84Copyright © Veeva Systems 2018
Data Ecosystem
EDC Datae.g. blood pressure
+ Lab Datae.g. urine test
+ Imagese.g. MRI
mHealthe.g. Apple Watch
+
![Page 85: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/85.jpg)
85Copyright © Veeva Systems 2018
CoderClinical Coding
EDCData Capture & Monitoring
Data WorkbenchCleaning, Reporting, Export
Reinventing Clinical Data ManagementOne product for coding, EDC, data cleaning, and data management
![Page 86: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/86.jpg)
86Copyright © Veeva Systems 2018
AP
I
ePRO
Labs
RTSM
Imaging
Biomarker
CRO, other..
Complete & Concurrent Data
Data LakeData Translation
Queries
CoderClinical Coding
EDCData Capture & Monitoring
Data WorkbenchCleaning, Reporting, Export
![Page 87: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/87.jpg)
87Copyright © Veeva Systems 2018
Accelerated time to submission
IT simplification
Significant reduction in data integration and
transfer costs
![Page 88: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/88.jpg)
Value of Veeva Development Cloud
![Page 89: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/89.jpg)
89Copyright © Veeva Systems 2018
future
Submissions
Submissions Archive
Registrations
Submissions Publishing
QualityDocs
QMS
Training
eTMF
CTMS
Study Startup
futureCDMS
Coder | EDC | Data Workbench
Coming Soon
![Page 90: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/90.jpg)
90Copyright © Veeva Systems 2018
Benefits of the Development Cloud
Reimagining processes
Vendor rationalization
Reduce data & document transfers & integration
Transformation
![Page 91: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/91.jpg)
91Copyright © Veeva Systems 2018
Customer Example with Disconnected Technology
Startup specialist reviews progress against site
milestones
Clinical QCs it for accuracy in an eTMF
Regulatory adds itto a submission in submissions tool
Study Startup eTMF Submissions
Investigator uploads a 1572 Form
Clinical Portal
Upload Export Import Export Import Export Import
![Page 92: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/92.jpg)
92Copyright © Veeva Systems 2018
Connected Across the Enterprise
Startup specialist reviews progress against site
milestones
Clinical QCs it for accuracy in
Vault eTMF
Regulatory adds itto a submission inVault Submissions
VaultStudy Startup
VaulteTMF
VaultSubmissions
Investigator uploads a 1572 Form
VaultClinical
![Page 93: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/93.jpg)
93Copyright © Veeva Systems 2018
Variation ManagementMaintaining compliance for a drug to be sold in a country
• Variations are required when any part of the drug process changes
• Required for every product in every country
• Complexity driven by product/country combinations
Examples
Mid-sized company
500 - 3,000 variations per year
Large company
Could be >10,000 variations per year
![Page 94: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/94.jpg)
94Copyright © Veeva Systems 2018
HQ TRIGGER NEW VARIATION
1. Organization triggers need for a Type IA Variation
2. Create new HQ tracking activity to manage request
3. Perform an impact assessment of the variation
4. Review the impact assessment in HQ tracking system (18 steps)
22. Approve the impact assessment
23. Identify impacted Affiliates
Post Approval Variation (Type 1A) Management
CONFIRM WITH LOCAL AFFILIATES
24. Email local affiliates with details of planned
variation
25. Affiliate performs local impact assessment
26. Follow-up with questions and requests
27. Local affiliate creates local request
tracking
BUILD SUBMISSION CORE PACKAGE(S)
28. Determine, based on the countries impacted, the Core Package needed for the
change
29. Identify affiliate groupings and types of submissions in each region
30. Build Submission Schedule for each group
31. Build appropriate Content Plans for each grouped set of affiliates (US, ROW, EU)
32. Agree Baseline submission schedules with Affiliates
33. Update tracking systems at HQ and Affiliates
34. Create the core package content & distribute (by email) to impacted Affiliates
BUILD THE LOCAL SUBMISSIONS
35. Receive and review the core
package
36. Create the local content to support
the local Submission including
translations
37. Assemble the local Submission &
Dispatch to the local HA
38. Update local tracking sheet
39. Archive to local Archive
HQ CLOSEOUT
40. Receive notification
from Affiliate of
dispatch
41. Update HQ tracking
system
42. Await local approvals
(chasing Affiliates,
weekly)
43. Update Registrations
System
![Page 95: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/95.jpg)
95Copyright © Veeva Systems 2018
DEMO
![Page 96: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/96.jpg)
96Copyright © Veeva Systems 2018
Results of Single System for Content and Data
from low process adherence to Full Compliance
from complex and siloed to Full Visibility and Control
from complex planning to Unified Collaboration
from slow and redundant to Improved Efficiency
from multiple systems 1 Unified Suite
from >43 steps to 1111
![Page 97: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/97.jpg)
97Copyright © Veeva Systems 2018
Summary
• Development cloud strategy is working
• Success in EDC has fueled the broader strategy for CDMS
• Clinical Network has transformational potential
• Execution and customer success
![Page 98: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/98.jpg)
Customer SuccessDan Utzinger, VP & CIO, Intra-Cellular Therapies
![Page 99: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/99.jpg)
Financial UpdateTim Cabral, CFO
![Page 100: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/100.jpg)
100Copyright © Veeva Systems 2018
Highlights
• Unique and Powerful Operating Model
• Consistent, Disciplined Execution
• Innovation Engine Fuels Long-term Growth
• Delivering Ahead of 2020 Target
![Page 101: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/101.jpg)
101Copyright © Veeva Systems 2018
Strong Growth and Profitability
Fiscal Year Ending January 31¹ A reconciliation of GAAP to non-GAAP measures is set forth in Appendix 1.² Restated for ASC 6063 Based on our latest guidance issued 8/23/2018
FY’12 FY’13 FY’14
Revenue Non-GAAP Operating Income1
$61M
$130M
$210M
$313M
$409M
$551M
$7M$30M
$47M
$86M$109M
$173M
FY’15 FY’16 FY’17²
$29M$5M
FY’11 FY’18²
$691M
$219M
FY’193
$840-843M
$281-284M
![Page 102: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/102.jpg)
102Copyright © Veeva Systems 2018
0
250
500
750
1000
1250
FY'14 FY'15 FY'16 FY'17 FY'18 FY'19
Generating Healthy Cash Balances
Cash & cash equivalents (end of period) Operating cash flow
IPO & Follow-on Proceeds
Zinc Acquisition
($M)
Fiscal Year Ending January 31¹ Based on our latest guidance issued 8/23/2018
¹
![Page 103: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/103.jpg)
103Copyright © Veeva Systems 2018
Progress Since IPO
$42M$47M$210M198
$5B
TAM Customers Revenue Non-GAAP OperatingIncome
Operating Cash Flow
FY2014
FY2019
650+$9B+ $840-843M $281-284M >$250M
6.0x 6.0x4.0x3.3x
1.8x
Note: FY2019 revenue, non-GAAP operating income and operating cash flow reflects guidance as of 8/23/2018
![Page 104: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/104.jpg)
104Copyright © Veeva Systems 2018
Approved EmaileTMF
Medcomms
CRMCLM
Promomats
INNOVATORS EARLY ADOPTERS EARLY MAJORITY MIDDLE MAJORITY LATER ADOPTERS
Innovation Engine Fuels Long Term GrowthDeep pipeline of products on the path to market leadership
CDMSNitro
SiteDocsTraining
CTMSEngage
PublishingQualityOne
QualityDocsRegistrationsSubmissionsSubs Archive
AlignEvents
NetworkOpenData
QMSStudy Startup
Market Share
![Page 105: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/105.jpg)
105Copyright © Veeva Systems 2018
Proven Reference Selling ModelDisciplined approach ensures success in new markets
Launch Product Win Early AdoptersFocus on Early
Adopter Success Reference Selling
![Page 106: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/106.jpg)
106Copyright © Veeva Systems 2018
One Year Ahead of Target:
Now Tracking to Hit $1B Revenue Run Rate in CY19
2014 2015 2016 2017 2018 2019 2020
$840M+
$551M
(FY17) (FY21)
$409M
$313M
(FY16)(FY15)
$691M
(FY18)
¹
Fiscal Year Ending January 31¹ Restated for ASC 6062Based on our latest guidance issued 8/23/2018 for total revenue of $840-843m
(FY19) (FY20)
2¹
Targeting 20%+ y-o-y subscription revenue growth through CY20
![Page 107: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/107.jpg)
107Copyright © Veeva Systems 2018
CY20FY19 Q2
Total Revenue Run Rate
~$400M ~$525M ~$665M ~$835M $1B+
Non-CRM as a % of Total Revenue
20%+ ~35% 40%+ ~50% 50%+
Eight-figure Customers
9 13 17 19 20
Customers 350 450+ 550+ 650+ 500+
Progress Against 2020 Targets
FY18 Q2FY17 Q2FY16 Q2
Note: Eight-figure customers are defined as those whose, at the parent company level, annualized value of subscription revenue as of the end of the period and the annualized value of professional services revenue in the last quarter of the period is at least $10m; the Q2’16 customer count is adjusted to include Zinc customers
![Page 108: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/108.jpg)
108Copyright © Veeva Systems 2018
Target Operating Model in 2020
Non2016
(FY17)2
2017 (FY18)2
2018 (FY19)3
Non-GAAP Gross Margin1 71% 71% ~73%
S&M % of Revenue (Non-GAAP)1 17% 16% ~16%
R&D % of Revenue (Non-GAAP)1 15% 17% ~17%
G&A % of Revenue (Non-GAAP)1 7% 7% ~7%
Non-GAAP Operating Margin1 31% 32% ~34%
- Continued scaling of field teams- Building the outside life sciences team
- Improved revenue mix- Greater Vault contribution to revenue
2020 (FY21)
75–76%
17–18%
17–18%
~7%
33–35%
Fiscal Year Ending January 31¹A reconciliation of GAAP to non-GAAP measures is set forth at Appendix 1.²Restated for ASC 6063Based on guidance provided as of 8/23/2018.
- Product innovation- Investment for future products
![Page 109: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/109.jpg)
109Copyright © Veeva Systems 2018
Execution Matters Most
![Page 110: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/110.jpg)
110Copyright © Veeva Systems 2018
On a Path to Multi-Billion Dollar Cloud Leader
• Continued Innovation and Significant Market Expansion
• Long-term Leadership in Strategic Markets
• Powerful and Unique Cloud Platform
• Business Model Advantage – The Veeva Way
![Page 111: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/111.jpg)
Appendix
![Page 112: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/112.jpg)
112Copyright © Veeva Systems 2018
Reconciliation of GAAP to non-GAAP Measures
Veeva is not able, at this time, to provide GAAP targets for operating income for the fiscal year ending January 31, 2019 because of the difficulty of estimating certain items excluded
from non-GAAP operating income that cannot be reasonably predicted, such as charges related to stock-based compensation expense, capitalization of internal-use software
development expenses and the subsequent amortization of the capitalized expenses, and deferred compensation associated with the Zinc Ahead acquisition. The effect of these
excluded items may be significant.
in millions FY'12 FY'13 FY'14 FY'15 FY'16 FY'17 FY'18
Operating income on a GAAP basis $ 7 $ 30 $ 39 $ 70 $ 79 $ 121 $ 158
Stock-based compensation expense — — 7 14 24 41 54
Amortization of purchased intangibles — — 1 2 5 8 8
Capitalization of internal-use software — — (1) — — — (2)
Amortization of internal-use software — — 1 — — — 1
Deferred compensation associated with Zinc Ahead acquisition — — — — 1 3 —
Operating income on a non-GAAP basis $ 7 $ 30 $ 47 $ 86 $ 109 $ 173 $ 219
![Page 113: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/113.jpg)
113Copyright © Veeva Systems 2018
Reconciliation of GAAP to non-GAAP Measures
Q2 FY'19
Gross margin on total revenues on a GAAP basis 71.7%
Stock-based compensation expense 1.5
Amortization of purchased intangibles 0.4
Amortization of internal-use software 0.1
Gross margin on total revenues on a non-GAAP basis 73.7%
in millions Q2 FY'19
Operating income on a GAAP basis $ 52.8
Stock-based compensation expense 19.7
Amortization of purchased intangibles 1.8
Capitalization of internal-use software (0.3)
Amortization of internal-use software 0.2
Deferred compensation associated with Zinc Ahead acquisition 0.1
Operating income on a non-GAAP basis $ 74.3
Q2 FY'19
Net income on a GAAP basis $ 50.3
Stock-based compensation expense 19.7
Amortization of purchased intangibles 1.8
Capitalization of internal-use software (0.3)
Amortization of internal-use software 0.2
Deferred compensation associated with Zinc Ahead acquisition 0.1
Income tax effect on non-GAAP adjustments (10.4)
Net income on a non-GAAP basis $ 61.4
![Page 114: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/114.jpg)
114Copyright © Veeva Systems 2018
Reconciliation of GAAP to non-GAAP Measures
Veeva is not able, at this time, to provide GAAP targets for gross margin, operating expenses or operating margin for the fiscal years ending January 31, 2019 and January 31, 2021 because of the difficulty of estimating certain items
excluded from non-GAAP gross margin, operating expenses and operating margin that cannot be reasonably predicted, such as charges related to stock-based compensation expense, capitalization of internal-use software development expenses and the subsequent amortization of the capitalized expenses, and deferred compensation associated with the Zinc Ahead acquisition. The effect of these excluded items may be significant.
FY'17 FY'18
Gross margin on total revenues on a GAAP basis 68.5% 69.4%
Stock-based compensation expense 1.3 1.4
Amortization of purchased intangibles 0.8 0.6
Amortization of internal-use software 0.1 0.1
Deferred compensation associated with Zinc Ahead acquisition — —
Gross margin on total revenues on a non-GAAP basis 70.7% 71.5%
FY'17 % of Revenue FY'18 % of Revenue
Sales and marketing expense on a GAAP basis 110.6$ 20% 128.8$ 19%
Stock-based compensation expense (13.3) (16.3)
Amortization of purchased intangibles (3.9) (3.9)
Deferred compensation associated with Zinc Ahead acquisition — —
Sales and marketing expense on a non-GAAP basis 93.4$ 17% 108.6$ 16%
FY'17 % of Revenue FY'18 % of Revenue
Research and development expense on a GAAP basis 96.7$ 18% 132.0$ 19%
Stock-based compensation expense (11.9) (17.8)
Capitalization of internal-use software 0.6 1.7
Deferred compensation associated with Zinc Ahead acquisition (0.4) (0.4)
Research and development expense on a non-GAAP basis 85.0$ 15% 115.5$ 17%
FY'17 % of Revenue FY'18 % of Revenue
General and administrative expense on a GAAP basis 48.8$ 9% 60.4$ 9%
Stock-based compensation expense (8.5) (10.0)
Deferred compensation associated with Zinc Ahead acquisition (2.3) —
General and administrative expense on a non-GAAP basis 38.0$ 7% 50.4$ 7.3%
FY'17 FY'18
Operating margin on a GAAP basis 21.9% 22.9%
Stock-based compensation expense 7.4 7.8
Amortization of purchased intangibles 1.5 1.1
Capitalization of internal-use software (0.1) (0.3)
Amortization of internal-use software 0.1 0.1
Deferred compensation associated with Zinc Ahead acquisition 0.5 0.1
Operating margin on a non-GAAP basis 31.3% 31.7%
![Page 115: Veeva Analyst & Investor Day...Started 2010 with Vault Separated company and product processes Five years to operational excellence Veeva as a Multi-Product Company Started 2016 with](https://reader034.vdocument.in/reader034/viewer/2022042304/5ecf4452b09e101b770aae89/html5/thumbnails/115.jpg)
115Copyright © Veeva Systems 2018
Veeva Application Financial Segment Definitions
Veeva Andi
Veeva CRM
Veeva CLM
Veeva CRM Approved Email
Veeva CRM Events Management
Veeva CRM Align
Veeva CRM Engage Meeting
Veeva CRM Engage Webinar
Veeva Network
Veeva Nitro
Veeva Oncology Link ( KOL Data)
Veeva OpenData
Vault CDMS
Vault CTMS
Vault eTMF
Vault MedComms
Vault Platform
Vault PromoMats
Vault Publishing
Vault QMS
Vault QualityDocs
Vault QualityOne
Vault Registrations
Vault SiteDocs
Vault Submissions
Vault SubmissionsArchive
Vault Study Startup
Vault Safety
Vault Training